Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Comprehensive pan-cancer analysis of YBX family reveals YBX2 as a potential biomarker in liver cancer.

Frontiers in immunology - 1 Jan 2024

Yuan Ze, Li Binbin, Liao Wenmin, Kang Da, Deng Xinpei, Tang Hailin, Xie Jindong, Hu Dandan, Chen Aiqin

Abstract excerpt

Background: The Y-box-binding proteins (YBX) act as a multifunctional role in tumor progression, metastasis, drug resistance by regulating the transcription and translation process. Nevertheless, their functions in a pan-cancer setting remain unclear. Methods: This study examined the clinical features expression, prognostic value, mutations, along with methylation patterns of three genes from the YBX family...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to DNA Methylation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Resistance, Neoplasm

Share to Gene Expression Profiling

Share to Gene Expression Regulation, Neoplastic

Share to Liver Neoplasms

Share to Tumor Microenvironment

Share to Y-Box-Binding Protein 1

Source

Open in PubMed Open full text

Identifiers

PMID: 38698857
DOI: 10.3389/fimmu.2024.1382520
PMCID: PMC11063299

Genes

YBX2
YBX1
YBX3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Comprehensive pan-cancer analysis of YBX family reveals YBX2 as a potential biomarker in liver cancer.PMID 38698857Read ↗

YBX1 as a prognostic biomarker and potential therapeutic target in hepatocellular carcinoma: A comprehensive investigation through bioinformatics analysis and in vitro studySemantic proximity Read ↗

Elevated YBX1 mRNA expression is associated with a genomically unstable and clinically aggressive cancer state: a pan-cancer analysisSemantic proximity Read ↗

Prognostic Significance and Immunological Role of FBXO5 in Human Cancers: A Systematic Pan-Cancer AnalysisSemantic proximity Read ↗

Pan-Cancer Analysis and Experimental Validation of SOX4 as a Potential Diagnosis, Prognosis, and Immunotherapy BiomarkerSemantic proximity Read ↗

Pan-Cancer Analysis Identifies YTHDF2 as an Immunological and Prognostic BiomarkerSemantic proximity Read ↗

Comprehensive Pan-Cancer Analysis on CBX3 as a Prognostic and Immunological BiomarkerSemantic proximity Read ↗

YTHDC1 serves as a potential therapeutic target and is linked with the immune microenvironment in Pan cancerSemantic proximity Read ↗

Comprehensive Analysis of the Expression, Prognostic Value and Correlations with Immune Infiltration of PBX Family Members in Colorectal CancerSemantic proximity Read ↗

Comprehensive pan-cancer analysis on CBX3 as a prognostic and immunological biomarkerSemantic proximity Read ↗

A Pan-Cancer Analysis of the Tumorigenic Role of Yin-Yang1 (YY1) in Human TumorsSemantic proximity Read ↗

The Pan-Cancer Multi-Omics Landscape of FOXO Family Relevant to Clinical Outcome and Drug ResistanceSemantic proximity Read ↗

Prognostic and immunological value of Chromobox family genes in Pan-CancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.